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Background: Analysis of exhaled breath condensates (EBC) is a non-invasive technique to evaluate biomarkers such as
antioxidants in the pediatric population, but limited data exists of its use in intubated patients, particularly newborns.
Currently, tracheal aspirate (TA) serves as the gold standard collection modality in critically ill newborns, but this
method remains invasive. We tested the hypothesis that glutathione status would positively correlate between EBC and
TA collections in intubated newborns in the Newborn Intensive Care Unit (NICU). We also hypothesized that these
measurements would be associated with alveolar macrophage (AM) glutathione status in the newborn lung.
Methods: Reduced glutathione (rGSH), glutathione disulfide (GSSG), and total GSH (rGSH + (2 X GSSG)) were measured
in sequential EBC and TA samples from 26 intubated newborns via high performance liquid chromatography (HPLC).
Additionally, AM glutathione was evaluated via immunofluorescence. Pearson’s correlation coefficient and associated
95% confidence intervals were used to quantify the associations between raw and urea-corrected concentrations in
EBC and TA samples and AM staining. Statistical significance was defined as p≤ 0.05 using two-tailed tests. The sample
size was projected to allow for a correlation coefficient of 0.5, with 0.8 power and alpha of 0.05.
Results: EBC was obtainable from intubated newborns without adverse clinical events. EBC samples demonstrated
moderate to strong positive correlations with TA samples in terms of rGSH, GSSG and total GSH. Positive correlations
between the two sampling sites were observed in both raw and urea-corrected concentrations of rGSH, GSSG and total
GSH. AM glutathione staining moderately correlated with GSSG and total GSH status in both the TA and EBC.
Conclusions: GSH status in EBC samples of intubated newborns significantly correlated with the GSH status of the TA
sample and was reflective of cellular GSH status in this cohort of neonatal patients. Non-invasive EBC sampling of
intubated newborns holds promise for monitoring antioxidant status such as GSH in the premature lung. Further
studies are necessary to evaluate the potential relationships between EBC biomarkers in the intubated premature
newborn and respiratory morbidities.
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Bronchopulmonary dysplasia (BPD) is a common compli-
cation of survivors of extreme prematurity, causing signifi-
cant morbidity and mortality among critically ill NICU
patients [1,2]. The precise pathophysiology of lung injury
remains under investigation but it remains clear that in-
flammation and oxidant stress amplify injury to the prema-
ture lung [3-5]. Antioxidant defenses such as glutathione
(GSH) are decreased in the premature newborn lung, pla-
cing them at increased risk for cellular injury from in-
creased production of reactive oxygen species [6]. Low
levels of GSH in the plasma and the bronchoalveolar fluid
(BAL) of premature newborns have been implicated in the
development of BPD [7,8], and the availability of GSH
modulates critical cellular functioning in the lung [9].
Current measurements of oxidant stress and inflamma-
tion include evaluation of samples obtained from airway
lavage, with tracheal aspirate (TA) sampling being the pri-
mary site for the premature newborn [10,11]. However, this
standard collection modality remains invasive for routine
use in newborns, particularly those born prematurely. In
recent years, analysis of the volatile and non-volatile con-
stituents in exhaled breath condensate (EBC) has evolved
as a novel means to non-invasively study oxidant markers
and inflammatory mediators in the airway surface liquid
[12-17]. Our laboratory has successfully used this method
in previous studies to investigate oxidant stress markers in
both asthmatic children [18] and adults [19].
Although TA samples are the mainstay of evaluating
samples obtained from premature newborns, there is a
lack of data regarding the correlation of the antioxidant
status between the TA sample and a non-invasive EBC
sample in neonates. We hypothesized that measurements
of GSH status obtained via TA collection and EBC col-
lection would positively correlate. Furthermore, since we
and others have demonstrated that AM GSH status is
dependent on the external milieu of GSH [9,20], we also
hypothesized that the GSH status of the EBC and TA
would be reflective of cellular GSH in isolated AM. There-
fore the goal of this study was to compare the GSH status
of a non-invasive EBC sample to its corresponding TA and
AM sample to determine whether EBC was reflective of
GSH within the neonatal lung and AM.
Methods
Subjects
Intubated newborns were enrolled from the NICU at
Children’s Healthcare of Atlanta at Egleston (CHOA), a
level IV intensive care unit within the Emory Division of
Neonatology System, in the city of Atlanta from January
2011 through October 2012. Informed consent was ob-
tained from guardians using procedures approved by
the Institutional Review Board at Emory University School
of Medicine (Gauthier, IRB00038093). All intubated babieswere eligible for enrollment. Exclusion criteria included
patients deemed too unstable by the attending neonatolo-
gist or those on high frequency ventilation, inhaled nitric
oxide, or extracorporeal membrane oxygenation (ECMO).
Clinical information was ascertained from the electronic
medical record.
Exhaled breath condensate (EBC) collection
Liquid condensate was collected from the exhaled breath
of mechanically ventilated newborns for 30 minutes. The
EBC collection device consisted of an RTUBE™ (Respira-
tory Research, Inc. Austin, TX) encased in an aluminum
cooling sleeve that was cooled to −80°C for at least 2
hours prior to use. A modified collection device was used
to collect EBC off the ventilator circuit. The RTUBE™ and
cooling sleeve, covered by a blue insulating cover, were
connected to the ETT and to the expiratory limb of the
ventilator circuit via valve-less connectors provided in
most standard ventilator circuits (Figure 1A). Figure 1B
depicts a simulated collection from an intubated neonatal
mannequin. Immediately after collection, the condensate
tubes were capped, placed on wet ice and transported to
the laboratory for analyses. The process of EBC collection
was monitored at the bedside by the investigators (MR,
SR, ET) and was tolerated well by all subjects, without sig-
nificant changes in heart rate, oxygen saturation or blood
pressure.
Tracheal aspirate (TA) collection
TA samples where obtained within one hour of EBC col-
lection. For the suctioning procedure, bacteriostatic sa-
line (~1 ml) was instilled into the trachea. After several
ventilator breaths, an in-line suction catheter (Ballard,
Kimberly-Clark, Irving, TX) was inserted just past the
endotracheal tube and the sample was then retrieved into
a closed, sterile Lukens trap (Covidien, Mansfield, MA).
Additional bacteriostatic saline was used if necessary to
clear the sample from the suction catheter. Samples were
immediately placed on wet ice and transported to the la-
boratory for analyses.
Sample processing and high performance liquid
chromatography (HPLC) analysis
Patients and samples were de-identified with a study num-
ber to ensure confidentiality. All samples were transported
to the laboratory on wet ice within an hour of collection. In
previous studies, we determined that the rate of oxidation
was ~5% per hour if the sample was maintained in a sterile
Lukens trap on wet ice [21]. TA samples were centrifuged
for 10 minutes to remove the cell pellet. EBC was extracted
from the RTUBE with a plunger apparatus. To prevent
auto-oxidation before analysis, 240 μL of the EBC was ali-
quoted into pre-made tubes containing 21 μL of a diluted
preservative with a final concentration of 5% perchloric
Figure 1 EBC collection from the expiratory limb of the ventilator. A) The RTUBE™ and its cooling sleeve covered by the blue insulated
cover where connected to the expiratory limb of the ventilator circuit via valve-less connectors. B) A simulated collection of EBC on an intubated
neonatal mannequin.
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nM of the internal standard γ-glutamyl-glutamate as we
have previously described [22]. For TA, 250 μL of sample
was added to pre-made tubes containing 250 μL of pre-
servative for a final concentration of 10% perchloric acid,
0.2 M boric acid, 13.4 mM IAA, and 10 μMγ-glutamyl-
glutamate. All samples were stored at −80°C until batch
analysis by HPLC, also previously described by this labora-
tory [21,23]. GSH and GSSG fractions were treated with
dansyl chloride and the dansylated derivatives separated
using an amino μBondaPak column (Waters, Milford MA)
with fluorescent detection. The lower limits of detection
were 15 fmol/μl for rGSH and were consistent with studies
by Komatsu and Obata [24] which used similar methods
and reported similar lower limits of detection. All of the
samples in this study were above the noted limits of detec-
tion. To minimize operational variability, all samples from
this study were analyzed within the same HPLC run.
Inter-assay coefficient of variability was determined by per-
forming HPLC analysis on a mixture of standards includ-
ing cysteine, cystine, rGSH, and GSSG. This mixture was
analyzed immediately before, in the middle and at the end
of sample set analysis. Based on this cocktail of standards,
the inter-assay coefficient of variability was calculated at
1%. Given the limited sample volume obtained, we were
unable to calculate intra-assay variability.
The subject’s blood urea nitrogen level (BUN, mg/dl)
was noted in the medical record on the day samples were
obtained. Sample urea was measured using the Bethleot/
Colorimetric assay (Pointe Scientific, Canton, MI - sensi-
tivity range of 0.05 to 150 mg/dl). Sample concentrations
of rGSH, GSSG and total GSH (defined as: GSH + (2 X
GSSG)) are presented as both raw values and urea cor-
rected values. Samples were corrected for dilution by
multiplication with the urea dilution factor (f) defined asf = Patient BUN/ sample urea used was as previously de-
scribed for EBC samples [21].
AM immunofluorescence
TA samples where centrifuged as noted above to obtain
cells (300 g, 10 minutes). The supernatant was processed
as above and the cell pellets where re-suspended in
RPMI 1640 media with 10% fetal calf serum (FCS) and
plated under sterile conditions for 1 hour. The media
was removed and the adhered cells washed three times
with phosphate buffered saline (PBS). Cells where then
fixed with 4% paraformaldehyde solution for 30 minutes,
washed with PBS and stored at 4°C. At the time of ana-
lysis non-specific binding was blocked with 10% bovine
serum albumin (BSA, 1 hour) and the cells were stained
for protein-glutathione adducts (primary mouse mono-
clonal IgG GSH, 2 hours) (Virogen, Watertown, MA).
After washing, a secondary Alexa fluorescence 488 green
anti-mouse IgG was added for 2 hours (Life Technolo-
gies, Carlsbad, CA). The cells were identified as AM by
cell morphology and then analyzed for fluorescence via
confocal fluorescent microscopy (Olympus FluoView
FV1000). The cellular fluorescence was quantified as rela-
tive fluorescent units (RFU) /cell as we previously de-
scribed [25].
Statistical analyses
All data were analyzed with SPSS® for Windows software
(Version 18.0, SPSS Inc., Chicago, IL) and SAS 9.3 (Cary,
NC). Prior to analysis, data were assessed for normality
using histograms, normal probability plots, and the
Kolmogorov-Smirnov test of normality. For concentra-
tions that were non-normally distributed, a log10 normal-
izing transformation was applied. Pearson’s correlation
coefficient and associated 95% confidence intervals were
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centrations. Scatter plots were used to assess whether the
relationship between two concentrations appeared linear
and to confirm that the Pearson’s correlation coefficient
was an appropriate measure of association. Statistical sig-
nificance was defined as p ≤ 0.05 using two-tailed tests. The
sample size was determined in order to detect a minimum




Twenty-six (26) intubated newborns on mechanical ven-
tilation were enrolled (Table 1). Enrolled subjects had a
median birthweight of 1564 grams (interquartile range
(IQR) 698, 2914 grams) and a median gestational age of
32.5 weeks (IQR: 24, 38 weeks). At the time of EBC and
TA collection, the median weight was 2280 grams (IQR:
1500, 3254 grams) with a corrected gestational age of 35
weeks (IQR: 34, 39.5 weeks). Subjects were ventilated for
a mean of 21 days (IQR: 7, 59.5 days) at the time of sam-
ple collection. As noted in Table 1, the majority of pa-
tients were admitted for surgical procedures.
GSH status was measureable in both TA and EBC samples
The median volume recovered from the TA was 0.75 ml
(IQR: 0.6, 1.75 ml) while the median EBC volume recov-
ered after 30 minutes of sampling was 2.2 ml (IQR: 1.5,
2.5 ml). GSH, GSSG and total GSH were detected by
HPLC in all samples (100%) in the nM range. The urea
dilution factors, raw concentrations, and urea-corrected
concentrations are presented in Table 2.
TA and EBC concentrations of rGSH and GSSG
significantly correlated
We postulated that rGSH and GSSG values measured in
the TA would correlate with those measured via a non-
invasive EBC. As seen in Figure 2, urea-corrected rGSH
in the TA demonstrated a moderate positive correlation
with urea-corrected rGSH in the EBC. Similarly, concen-
trations of TA rGSH not normalized to urea moderately
correlated with EBC rGSH concentrations not normal-
ized to urea (r = 0.574, p = 0.002, 95% CI: (0.230-0.782),
R2 = 0.329). Interestingly, the duration of mechanical ven-
tilation demonstrated a moderate negative correlation
with urea-corrected rGSH in the EBC (r = − 0.574, p =
0.003, 95% CI: (−0.779 – (−0.209), R2 = 0.329) but did not
correlate with urea-corrected rGSH in the TA (p =NS).
Figure 3 demonstrates a strong positive correlation be-
tween urea-corrected GSSG in the TA and urea-corrected
GSSG in the EBC. A similarly strong positive correlation
existed between TA GSSG concentrations not normalized
by urea and EBC GSSG concentrations not normalized to
urea (r = 0.708, p < 0.001, 95% CI: (0.431 – 0.856), R2 =0.501). Although the fraction of oxidized GSH (i.e. the %
GSSG) was approximately two times higher in the EBC
than in the TA (EBC: 44.8 ± 4.6% vs TA: 21.8 ± 3%, p <
0.001), there was no significant correlation between the
TA % GSSG and the EBC % GSSG (p =NS). When total
GSH was compared between the two sampling sites, a
moderate positive correlation was demonstrated in both
urea-corrected values (Figure 4) and in non-urea normal-
ized values (r = 0.649, p < 0.001, 95% CI: (0.338 – 0.824),
R2 = 0.421).
GSH status in both TA and EBC correlated with AM
GSH staining
Since we hypothesized that the GSH in the TA or EBC
sample may be reflective of cellular GSH in the isolated
AM, we evaluated the correlation of total GSH mea-
sured in TA and EBC with AM GSH staining deter-
mined via immunofluorescence. Fluorescent staining for
protein-GSH adducts in the AM demonstrated a moder-
ate positive correlation with the urea-corrected concen-
tration of total GSH in the TA and the EBC (Figure 5A
and B). Furthermore, AM demonstrated a moderate posi-
tive correlation with urea-corrected concentrations of
GSSG in the TA (Figure 6A) and in the EBC (Figure 6B).
While we did not observe a correlation between AM GSH
and urea-corrected concentrations of rGSH in the TA
(p =NS), a moderate positive correlation was found with
urea-corrected concentrations of rGSH in the EBC (r =
0.571, p = 0.004, 95% CI: (0.195 – 0.791), R2 = 0.326).
Discussion
In the current investigation, our main goals were 1) to
determine if the status of the antioxidant GSH measured
in a TA sample correlated with that of a corresponding
EBC sample and 2) to determine whether EBC collection
enabled a safe, non-invasive approach to evaluate such
data in an intubated neonatal population. No adverse
events where noted during EBC collection in our series
of ventilated neonatal patients. Both the raw and urea-
corrected concentrations of EBC rGSH, GSSG and total
GSH significantly correlated with those measurements
in the more invasive TA samples. Furthermore, this study
demonstrated that both the total GSH and the GSSG in
TA and EBC samples positively correlated with the cellu-
lar GSH staining of isolated AM.
Collection of EBC is based on the premise that airway
surface liquid droplets are entrained and mixed with
water vapor and other volatile gases during tidal breathing
[17]. Upon exhalation, the breath is cooled in a passive
sampling device which causes water vapor to condense
into respiratory droplets plus other exhaled particles and
collect on the chilled walls of the sampling device. Investi-
gations into the use of EBC as a non-invasive tool to moni-
tor pulmonary biomarkers of disease have gained much
Table 1 Patient demographics
Subject number GA (weeks) GA at sample
collection (weeks)







1 37 40 2442 2760 3 21 Hypoglossia-hypodactylia syndrome
2 24 27 675 1000 6 21 Spontaneous intestinal perforation
3 26 35 686 1730 3 189 Patent ductus arteriosus
4 24 35 690 3780 8 77 Subglottic stenosis
5 35 42 1980 3000 12 49 Congenital diaphragmatic hernia
6 41 42 3530 4060 10 7 Esophageal atresia/tracheal esophageal fistula
7 39 40 3800 3850 5 7 Neonatal seizures
8 37 40 2782 3365 7 21 Laryngeal cleft
9 26 34 803 1650 5 56 Jejunal stricture
10 24 34 720 1895 1 70 Pneumoperitoneum
11 24 30 760 1380 18 42 Necrotizing enterocolitis
12 38 40 3100 2940 19 14 Gastroschisis
13 38 39 2858 2858 13 7 Gastroschisis
14 39 40 3080 3265 18 7 Imperforate anus/congenital heart disease
15 35 36 2440 2440 16 7 Gastroschisis
16 24 26 700 810 29 14 Spontaneous intestinal perforation
17 38 38 3590 3590 12 5 Congenital diaphragmatic hernia
18 31 33 1417 1100 26 14 Congenital heart disease, duodenal atresia
19 34 34 2120 2120 15 4 Multiple jejunal atresias
20 35 43 1710 2500 16 56 Intestinal perforation, microcolon
21 39 41 3170 3250 41 14 Pentalogy of cantrell
22 25 37 450 1530 33 84 Extreme prematurity
23 24 32 550 1200 18 56 Extreme prematurity
24 23 34 610 1410 2 77 Spontaneous intestinal perforation
25 27 35 1110 1900 3 56 Patent ductus arteriosus












Table 2 rGSH, GSSG and total GSH are measurable in
both TA and EBC samples
TA EBC
Collected fluid volume (ml) 0.75 (0.6, 1.75) 2.2 (1.5, 2.5)
Sample urea (mg/dl) 11.2 (3.8, 28.0) 3.3 (3.1, 28.3)
Urea dilution factor 0.69 (0.42, 3.77) 0.90 (0.49, 4.87)
Sample GSH (raw values, nM)
rGSH 155 (71, 1087) 0.5 (0.4, 37)
GSSG 112.0 (7.9, 345) 1.0 (0.8, 10.9)
Total GSH 273 (107, 1831) 2.3 (2.1, 63.7)
Sample GSH (urea-corrected
values, nM)
rGSH 225 (107, 562) 3.8 (0.5, 12.2)
GSSG 45.5 (20.9, 191) 4.3 (1.3, 8.6)
Total GSH 289 (195, 884) 12 (3.6, 28.1)
Values are presented as median (IQR)
r = 0.700, p < 0.001, 95% CI: (0.401 – 0.856), R2 = 0.490









Figure 3 Relationship between TA GSSG and EBC GSSG. A
strong positive correlation is seen between TA and EBC GSSG. Points
represent the values of urea-corrected concentrations of GSSG in
nM. Correlations were calculated after log10 normalization.
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novel observations about the antioxidant status of the lung
in varying disease states in both the adult and pediatric
population [16,26]. Our laboratory has successfully used
this method in previous studies to demonstrate diminished
GSH availability in the lungs of asthmatic children [18]
and adults [19].
Although EBC use has widely been studied with the
hopes of utilizing this technique in clinical practice in
the adult arena [12], data investigating EBC in newborn
infants remains limited. Evaluation of EBC has been de-
scribed in spontaneously breathing infants with a median
age of approximately 2 years [27] and in older childrenr = 0.571, p = 0.005, 95% CI: (0.184 – 0.795), R2 = 0.326
100
1000






Figure 2 Relationship between TA rGSH and EBC rGSH. TA and
EBC rGSH demonstrated a moderate positive correlation. Points
represent the values of urea-corrected concentrations of rGSH in nM.
Correlations were calculated after log10 normalization.between 1–30 months of age [28]. Collection of EBC via
the exhalation limb of the ventilator has been reported in
intubated pediatric patients [29] and in neonates requiring
mechanical ventilation or CPAP [30]. However, the current
study is the first report to our knowledge aimed at compar-
ing TA and EBC samples in an exclusively intubated neo-
natal population. Our data suggest significant correlations
existed between EBC and TA GSH markers in neonates,
unlike studies in adult subjects, where EBC and BALr = 0.657, p < 0.001, 95% CI: (0.322 – 0.834), R2 = 0.431








Figure 4 Relationship between TA Total GSH and EBC Total
GSH. Total GSH (GSH + (2 X GSSG)) had a moderate positive
correlation between the two sampling sites. Points represent the
values of urea-corrected concentrations of total GSH in nM.
Correlations were calculated after log10 normalization.
r = 0.521, p = 0.014, 95% CI: (0.103 – 0.773), R2 = 0.271














Figure 5 Relationship between TA and EBC total GSH and AM GSH staining. Total GSH concentrations in the A) TA and B) EBC as measured
via HPLC were compared to GSH staining on the isolated AM as determined by immunofluorescence. A) A moderate positive correlation existed
between TA total GSH and AM GSH stain. B) A moderately positive correlation also exists between EBC total GSH and AM GSH. Points represent
the values of urea-corrected total GSH concentrations in nM on the Y axis versus AM GSH stain as quantified in relative fluorescent units (RFU)/cell on
the X axis. Correlations were calculated after log10 normalization of the total GSH concentrations.
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hydrogen peroxide did not correlate [31].
The strengths of the current study include a standard-
ized approach to the collection of the EBC in terms of
methodology and timing. EBC was collected from the
exhalation limb of the ventilator in intubated newborns
which reduced possible contamination from volatiles in
the atmosphere or the mouth as has been demonstrated
in spontaneously breathing subjects [12-14].
This study has several limitations. The goal of this pro-
ject was to determine correlations between non-invasive
EBC collection and TA collection; for this reason EBC and












Figure 6 Relationship between TA and EBC GSSG and AM GSH stainin
GSH staining on the isolated AM. A) A moderate positive correlation existe
positive correlation also exists between GSSG in the EBC and AM GSH. Poin
on the Y axis versus AM GSH stain as quantified in relative fluorescent unit
normalization of the total GSH concentrations.to compare them to each other and not between popula-
tion subsets. As such, the sample size of this pilot study
was small. A much larger sample size would be required
to appropriately control for gestational age, chronological
age of the newborn, and respiratory diagnosis. However,
data from this pilot study justifies a much larger, ad-
equately powered clinical study aimed to define normative
values in such a neonatal population.
During the study we did not monitor temperature sta-
bility throughout sample collections. The R-Tubes were
precooled to −80°C for a minimum of 2 hours, kept in an
insulated glove and placed on wet ice prior to and imme-




g. GSSG concentration in the A) TA and B) EBC were compared to
d between GSSG in the TA and AM GSH stain. B) A moderately
ts represent the values of urea-corrected GSSG concentrations in nM
s (RFU)/cell on the X axis. Correlations were calculated after log10
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varying temperature has been noted to affect EBC analyses
[13,14,32-34].
The standardization of EBC analyses remains limited
since normalization for dilution within the EBC samples
remains problematic. Current literature outlines an on-
going debate regarding the interpretation of dilution in
EBC sampling [17,35-37]. While we attempted to control
for dilution using the urea-correction, as is acceptable for
BAL analyses, it remains unknown whether this method
is applicable to EBC sampling [14]. Although the use of
urea-correction for EBC is not yet established, our data
suggest that this may be an appropriate method to address
the effects of dilution in both TA and EBC sampling, since
similar correlations were noted.
Investigations into the GSH status of premature new-
borns remain clinically important. Advances in modern
neonatal respiratory support and clinical interventions for
the prevention or treatment of BPD have not succeeded in
reducing its occurrences [2]. Therefore, continued investi-
gations into the antioxidant status of the at-risk premature
newborn lung may allow patient-specific therapies to im-
prove respiratory outcomes in this at-risk population [38].
Even though the thiol pair of GSH/GSSG is essential for
normal cellular functioning and signaling in the lung [39],
there remains limited information regarding its abundance
in the premature newborn [8], who is particularly at risk
for both inflammatory [40] and oxidative injury [6]. TA
sampling, albeit less invasive than a formal BAL, still re-
quires invasive suctioning of the airway. EBC holds poten-
tial as a non-invasive approach to evaluating GSH status
in the neonatal lung, and to assist in identifying those par-
ticular infants at greatest risk for the development of BPD.
The current study demonstrates feasibility of this ap-
proach in an intubated neonatal population. Interestingly,
a moderate negative correlation was demonstrated be-
tween EBC rGSH and the duration of mechanical ventila-
tion at the time of sample collection. Furthermore, since
GSH availability modulates functioning of the resident
AM [9,25], determining the status of GSH availability in
the developing lung could advance our understanding of
the mechanisms underlying antioxidant depletion and the
development of BPD in the neonate.
Conclusion
EBC collection in intubated neonates was well tolerated
without significant changes in respiratory status. GSH sta-
tus in the EBC positively correlated with that obtained in
the more invasive TA, and positively correlated with that
seen in isolated AM. Evaluation of EBC holds promise to
monitor antioxidant status, such as GSH in premature new-
borns. Further investigations are required to incorporate
this technology to assist in identifying those infants at great-
est risk for subsequent oxidant-induced injury in the lung.Abbreviations
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